首页> 外文期刊>American Journal of Transplantation >Height Contributes to the Gender Difference in Wait-List Mortality Under the MELD-Based Liver Allocation System
【24h】

Height Contributes to the Gender Difference in Wait-List Mortality Under the MELD-Based Liver Allocation System

机译:在基于MELD的肝分配系统下,身高导致候诊死亡率的性别差异

获取原文
获取原文并翻译 | 示例
           

摘要

This study examined factors associated with the gender disparity in wait-list mortality in the MELD era. Adult patients listed for liver transplantation from 2002 to 2008 were included. Females [12 585(36%)] and males [22 126(64%)] differed clinically by age (54 vs. 52 years), height (1.6 vs. 1.8 m), listing estimated glomerular filtration rate [(eGFR); 70 vs. 83 mL/min] and cirrhosis etiology. Holding MELD constant, females were at 19% (95% CI, 1.13–1.25, p < 0.001) higher risk of wait-list mortality than males under the current allocation system. The relative hazard increased with worsening renal function, whether measured by serum creatinine or eGFR. Adjustment for MELD, age, African-American race, cirrhosis etiology, region and ABO group attenuated this relative hazard (HR 1.16; 95% CI, 1.10–1.22; p < 0.001) but additional adjustment for height completely explained this gender disparity in wait-list mortality (HR 1.05; 95% CI, 0.98–1.12; p = 0.2). Transplantation rates, however, remained lower among females, even after adjustment for height (HR 0.88; 95% CI, 0.82–0.92; p < 0.001). In conclusion, under the current liver allocation system, women have a 19% increased risk of wait-list mortality compared to men with the same MELD scores. Height contributes to this gender disparity, possibly reflecting differences in transplantation rates for shorter individuals.
机译:这项研究调查了MELD时代候诊死亡率中与性别差异有关的因素。包括2002年至2008年列为肝移植的成年患者。女性[12 585(36%)]和男性[22 126(64%)]在临床上因年龄(54岁对52岁),身高(1.6岁对1.8 m)不同而不同,其中列出了估计的肾小球滤过率[(eGFR); 70 vs. 83 mL / min]和肝硬化的病因。保持MELD不变,在当前分配制度下,女性的等待名单死亡风险比男性高19%(95%CI,1.13–1.25,p <0.001)。无论是通过血清肌酐还是eGFR衡量,相对危险随着肾功能恶化而增加。对MELD,年龄,非裔美国人种族,肝硬化病因,地区和ABO组的调整减轻了这种相对危险(HR 1.16; 95%CI,1.10–1.22; p <0.001),但是对身高的额外调整完全解释了这种性别差异列表死亡率(HR 1.05; 95%CI,0.98-1.12; p = 0.2)。然而,即使调整身高,女性的移植率仍然较低(HR 0.88; 95%CI,0.82-0.92; p <0.001)。总之,在目前的肝脏分配制度下,与具有相同MELD评分的男性相比,女性的等待名单死亡率增加了19%。身高加剧了这种性别差异,可能反映了矮个子个体的移植率差异。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号